TY - CHAP M1 - Book, Section TI - Relatlimab and nivolumab provide greater survival benefit for advanced melanoma A1 - Xiang, David A1 - Shah, Harsh Y1 - 2015 N1 - T2 - 2 Minute Medicine AB - SN - PB - McGraw Hill CY - New York, NY Y2 - 2024/03/29 UR - accessmedicina.mhmedical.com/updatesContent.aspx?gbosid=579756 ER -